v3.25.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Total
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023 $ 0 $ 0 $ 14,897 $ 6,917,774 $ (8,960,981) $ (2,028,310)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023 0 0 14,896,791      
NET LOSS $ 0 $ 0 $ 0 0 (425,942) (425,942)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2024 $ 0 $ 0 $ 14,897 6,917,774 (9,386,923) (2,454,252)
Shares, Outstanding, Ending Balance at Mar. 31, 2024 0 0 14,896,791      
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2023 $ 0 $ 0 $ 14,897 6,917,774 (8,960,981) (2,028,310)
Shares, Outstanding, Beginning Balance at Dec. 31, 2023 0 0 14,896,791      
Common stock issued to settle accounts payable and accrued expenses           26,250
NET LOSS           (1,356,761)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2024 $ 0 $ 0 $ 5,482 6,953,439 (10,317,742) (3,358,821)
Shares, Outstanding, Ending Balance at Sep. 30, 2024 0 0 5,481,619      
Common stock issued to settle accrued expenses - related party           0
Common stock issued to settle accrued interest           0
Exchange of common stock for Series A Preferred Stock           9,794
Equity, Attributable to Parent, Beginning Balance at Mar. 31, 2024 $ 0 $ 0 $ 14,897 6,917,774 (9,386,923) (2,454,252)
Shares, Outstanding, Beginning Balance at Mar. 31, 2024 0 0 14,896,791      
NET LOSS $ 0 $ 0 $ 0 0 (470,675) (470,675)
Equity, Attributable to Parent, Ending Balance at Jun. 30, 2024 $ 0 $ 0 $ 14,897 6,917,774 (9,857,598) (2,924,927)
Shares, Outstanding, Ending Balance at Jun. 30, 2024 0 0 14,896,791      
Common stock issued to settle accounts payable and accrued expenses $ 0 $ 0 $ 379 25,871 0 26,250
Common stock issued to settle accounts payable and accrued expenses, shares     378,582      
NET LOSS 0 0 $ 0 0 (460,144) (460,144)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2024 $ 0 $ 0 $ 5,482 6,953,439 (10,317,742) (3,358,821)
Shares, Outstanding, Ending Balance at Sep. 30, 2024 0 0 5,481,619      
Exchange of common stock for Series A Preferred Stock $ 0 $ 0 $ (9,794) 9,794 0 0
Exchange of common stock for Series A Preferred Stock Shares   0 (9,793,754)      
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2024 $ 200 $ 0 $ 39,991 7,374,297 (10,809,256) (3,394,768)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024 200,000 0 39,990,903      
Common stock issued to settle accounts payable and accrued expenses $ 0 $ 0 $ 5,253 143,941 0 149,194
Common stock issued to settle accounts payable and accrued expenses, shares     5,253,234      
NET LOSS 0       (591,397) (591,397)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2025 $ 200 $ 0 $ 45,244 7,518,238 (11,400,653) (3,836,971)
Shares, Outstanding, Ending Balance at Mar. 31, 2025 200,000 0 45,244,137      
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2024 $ 200 $ 0 $ 39,991 7,374,297 (10,809,256) (3,394,768)
Shares, Outstanding, Beginning Balance at Dec. 31, 2024 200,000 0 39,990,903      
Common stock issued to settle accounts payable and accrued expenses           330,431
NET LOSS           (1,607,467)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2025 $ 200 $ 0 $ 318,890 8,212,004 (12,416,723) (3,885,629)
Shares, Outstanding, Ending Balance at Sep. 30, 2025 200,000 0 318,890,559      
Common stock issued to settle accrued expenses - related party $ 0 $ 0 $ 75,000 150,000 0 $ 225,000
Common stock issued to settle accrued expenses - related party     75,000,000     75,000,000
Common stock issued to settle accrued interest           $ 323,453
Common stock issued to settle accrued interest     38,971,457      
Exchange of common stock for Series A Preferred Stock           0
Equity, Attributable to Parent, Beginning Balance at Mar. 31, 2025 $ 200 $ 0 $ 45,244 7,518,238 (11,400,653) (3,836,971)
Shares, Outstanding, Beginning Balance at Mar. 31, 2025 200,000 0 45,244,137      
Common stock issued to settle accounts payable and accrued expenses $ 0 $ 0 $ 6,381 108,429 0 114,810
Common stock issued to settle accounts payable and accrued expenses, shares     6,380,952      
NET LOSS 0 0 $ 0 0 (486,149) (486,149)
Equity, Attributable to Parent, Ending Balance at Jun. 30, 2025 $ 200 $ 0 $ 51,625 7,626,667 (11,886,802) (4,208,310)
Shares, Outstanding, Ending Balance at Jun. 30, 2025 200,000 0 51,625,089      
Exchange of common stock for Series A Preferred Stock Shares     (9,793,754)      
Common stock issued to settle accounts payable and accrued expenses $ 0 $ 0 $ 29,670 85,837 0 115,507
Common stock issued to settle accounts payable and accrued expenses, shares     29,669,748      
NET LOSS 0 0 $ 0 0 (529,921) (529,921)
Equity, Attributable to Parent, Ending Balance at Sep. 30, 2025 $ 200 $ 0 $ 318,890 8,212,004 (12,416,723) (3,885,629)
Shares, Outstanding, Ending Balance at Sep. 30, 2025 200,000 0 318,890,559      
Common stock issued to settle accrued expenses - related party           225,000
Common stock issued to settle accrued interest $ 0 $ 0 $ 38,971 102,251 0 141,222
Common stock issued to settle accrued interest     38,971,457      
Common stock issued for cash and settlement of accrued interest, net of issuance costs 0 0 $ 106,958 213,915 0 320,873
Common stock issued for cash and settlement of accrued interest, net of issuance costs     106,957,599      
Issuance of shares of common stock for cash $ 0 $ 0 $ 16,666 $ 33,334 $ 0 $ 50,000
Issuance of shares of common stock for cash     16,666,666